These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20797314)

  • 1. The effect of CYP1A2 gene polymorphisms on Theophylline metabolism and chronic obstructive pulmonary disease in Turkish patients.
    Uslu A; Ogus C; Ozdemir T; Bilgen T; Tosun O; Keser I
    BMB Rep; 2010 Aug; 43(8):530-4. PubMed ID: 20797314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy.
    Takata K; Saruwatari J; Nakada N; Nakagawa M; Fukuda K; Tanaka F; Takenaka S; Mihara S; Marubayashi T; Nakagawa K
    Eur J Clin Pharmacol; 2006 Jan; 62(1):23-8. PubMed ID: 16385402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequencies of four genetic polymorphisms in the CYP1A2 gene in Turkish population.
    Bilgen T; Tosun O; Luleci G; Keser I
    Genetika; 2008 Aug; 44(8):1133-6. PubMed ID: 18825963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of serum theophylline concentrations and cytochrome P450 1A2 activity by analyzing urinary metabolites in preterm infants.
    Sohn JA; Kim HS; Oh J; Cho JY; Yu KS; Lee J; Shin SH; Lee JA; Choi CW; Kim EK; Kim BI; Park EA
    Br J Clin Pharmacol; 2017 Jun; 83(6):1279-1286. PubMed ID: 27995649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism.
    Sachse C; Bhambra U; Smith G; Lightfoot TJ; Barrett JH; Scollay J; Garner RC; Boobis AR; Wolf CR; Gooderham NJ;
    Br J Clin Pharmacol; 2003 Jan; 55(1):68-76. PubMed ID: 12534642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association of cytochrome P450 genes polymorphisms (CYP1A1 and CYP1A2) with the development of chronic obstructive pulmonary disease in Bashkortostan].
    Korytina GF; Akhmadishina LZ; Kochetova OV; Zagidullin ShZ; Viktorova TV
    Mol Biol (Mosk); 2008; 42(1):32-41. PubMed ID: 18389617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between common CYP1A2 polymorphisms and theophylline metabolism in non-smoking healthy volunteers.
    Wang L; Hu Z; Deng X; Wang Y; Zhang Z; Cheng ZN
    Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):257-63. PubMed ID: 23167834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP1A2*1D and *1F polymorphisms have a significant impact on olanzapine serum concentrations.
    Czerwensky F; Leucht S; Steimer W
    Ther Drug Monit; 2015 Apr; 37(2):152-60. PubMed ID: 25090458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the genetic polymorphism in the 5'-noncoding region of the CYP1A2 gene on CYP1A2 phenotype and urinary mutagenicity in smokers.
    Pavanello S; Pulliero A; Lupi S; Gregorio P; Clonfero E
    Mutat Res; 2005 Nov; 587(1-2):59-66. PubMed ID: 16188490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma.
    Obase Y; Shimoda T; Kawano T; Saeki S; Tomari SY; Mitsuta-Izaki K; Matsuse H; Kinoshita M; Kohno S
    Clin Pharmacol Ther; 2003 May; 73(5):468-74. PubMed ID: 12732846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between CYP2E1 promoter polymorphisms and plasma 1,3-dimethyluric acid/theophylline ratios.
    Yoon Y; Park HD; Park KU; Kim JQ; Chang YS; Song J
    Eur J Clin Pharmacol; 2006 Aug; 62(8):627-31. PubMed ID: 16841220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of theophylline in adult Chinese patients with asthma and chronic obstructive pulmonary disease.
    Ma Y; Xue L; Chen X; Kang Y; Wang Y; Wang L
    Int J Clin Pharm; 2018 Oct; 40(5):1010-1018. PubMed ID: 29777329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cytochrome P450 CYP1A2 genetic polymorphisms *1F and *1D do not affect clozapine clearance in a group of schizophrenic patients.
    Kootstra-Ros JE; Smallegoor W; van der Weide J
    Ann Clin Biochem; 2005 May; 42(Pt 3):216-9. PubMed ID: 15949157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer.
    Li D; Jiao L; Li Y; Doll MA; Hein DW; Bondy ML; Evans DB; Wolff RA; Lenzi R; Pisters PW; Abbruzzese JL; Hassan MM
    Carcinogenesis; 2006 Jan; 27(1):103-11. PubMed ID: 15987714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional polymorphisms of the cytochrome P450 1A2 (CYP1A2) gene and prolonged QTc interval in schizophrenia.
    Tay JK; Tan CH; Chong SA; Tan EC
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1297-302. PubMed ID: 17611010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans.
    Ghotbi R; Christensen M; Roh HK; Ingelman-Sundberg M; Aklillu E; Bertilsson L
    Eur J Clin Pharmacol; 2007 Jun; 63(6):537-46. PubMed ID: 17370067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a high throughput single nucleotide polymorphism screening method for the cytochrome P450 1A2 polymorphisms CYP1A2*1C and CYP1A2*1F: are they useful as predictive markers in mental disorders?
    Klemm M; Eidens M; Lorenz M; Prause S; Weise A; Dahmen N; Forst T; Pfützner A
    Clin Lab; 2010; 56(9-10):473-80. PubMed ID: 21086794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Age-dependent CYP1A2 gene polymorphism -163C>A in three ethnic groups of Bashkortostan Republic residents].
    Érdman VV; Nasibullin TR; Tuktarova IA; Korytina GF; Akhmadishina LZ; Kochetova OV; Mustafina OE
    Adv Gerontol; 2014; 27(3):412-7. PubMed ID: 25826985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of genetic polymorphisms, smoking, gender and age on CYP1A2 activity in a Turkish population.
    Gunes A; Ozbey G; Vural EH; Uluoglu C; Scordo MG; Zengil H; Dahl ML
    Pharmacogenomics; 2009 May; 10(5):769-78. PubMed ID: 19450128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotyping of four genetic polymorphisms in the CYP1A2 gene in the Egyptian population.
    Hamdy SI; Hiratsuka M; Narahara K; Endo N; El-Enany M; Moursi N; Ahmed MS; Mizugaki M
    Br J Clin Pharmacol; 2003 Mar; 55(3):321-4. PubMed ID: 12630986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.